Associations between lifetime classic psychedelic use and cardiometabolic diseases

The objective of the current study was to investigate the associations between lifetime classic psychedelic use and cardiometabolic diseases. Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use a...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonsson, Otto, Osika, Walter, Carhart-Harris, Robin, Hendricks, Peter S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277805/
https://www.ncbi.nlm.nih.gov/pubmed/34257396
http://dx.doi.org/10.1038/s41598-021-93787-4
_version_ 1783722131595460608
author Simonsson, Otto
Osika, Walter
Carhart-Harris, Robin
Hendricks, Peter S.
author_facet Simonsson, Otto
Osika, Walter
Carhart-Harris, Robin
Hendricks, Peter S.
author_sort Simonsson, Otto
collection PubMed
description The objective of the current study was to investigate the associations between lifetime classic psychedelic use and cardiometabolic diseases. Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes. Respondents who reported having tried a classic psychedelic at least once in their lifetime had lower odds of heart disease in the past year (adjusted odds ratio (aOR) = 0.77 (0.65–0.92), p = .006) and lower odds of diabetes in the past year (adjusted odds ratio (aOR) = 0.88 (0.78–0.99), p = .036). Classic psychedelic use might be beneficial for cardiometabolic health, but more research is needed to investigate potential causal pathways of classic psychedelics on cardiometabolic diseases.
format Online
Article
Text
id pubmed-8277805
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82778052021-07-15 Associations between lifetime classic psychedelic use and cardiometabolic diseases Simonsson, Otto Osika, Walter Carhart-Harris, Robin Hendricks, Peter S. Sci Rep Article The objective of the current study was to investigate the associations between lifetime classic psychedelic use and cardiometabolic diseases. Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes. Respondents who reported having tried a classic psychedelic at least once in their lifetime had lower odds of heart disease in the past year (adjusted odds ratio (aOR) = 0.77 (0.65–0.92), p = .006) and lower odds of diabetes in the past year (adjusted odds ratio (aOR) = 0.88 (0.78–0.99), p = .036). Classic psychedelic use might be beneficial for cardiometabolic health, but more research is needed to investigate potential causal pathways of classic psychedelics on cardiometabolic diseases. Nature Publishing Group UK 2021-07-13 /pmc/articles/PMC8277805/ /pubmed/34257396 http://dx.doi.org/10.1038/s41598-021-93787-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Simonsson, Otto
Osika, Walter
Carhart-Harris, Robin
Hendricks, Peter S.
Associations between lifetime classic psychedelic use and cardiometabolic diseases
title Associations between lifetime classic psychedelic use and cardiometabolic diseases
title_full Associations between lifetime classic psychedelic use and cardiometabolic diseases
title_fullStr Associations between lifetime classic psychedelic use and cardiometabolic diseases
title_full_unstemmed Associations between lifetime classic psychedelic use and cardiometabolic diseases
title_short Associations between lifetime classic psychedelic use and cardiometabolic diseases
title_sort associations between lifetime classic psychedelic use and cardiometabolic diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277805/
https://www.ncbi.nlm.nih.gov/pubmed/34257396
http://dx.doi.org/10.1038/s41598-021-93787-4
work_keys_str_mv AT simonssonotto associationsbetweenlifetimeclassicpsychedelicuseandcardiometabolicdiseases
AT osikawalter associationsbetweenlifetimeclassicpsychedelicuseandcardiometabolicdiseases
AT carhartharrisrobin associationsbetweenlifetimeclassicpsychedelicuseandcardiometabolicdiseases
AT hendrickspeters associationsbetweenlifetimeclassicpsychedelicuseandcardiometabolicdiseases

Ejemplares similares